Zurich, Switzerland, October 7, 2026 - MUVON Therapeutics AG, a clinical-stage biotechnology company, reports positive 12-month interim results from the Long-Term Follow-Up Study of the Phase 2 ...
Even one of these deals can satisfy your shopping itch — without the buyer’s remorse.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results